Regulation of carcinoma cell invasion by protein C inhibitor whose expression is decreased in renal cell carcinoma

International Journal of Cancer

Volumn 108, Issue 4, 2004, Pages 516-523

  Wakita, Toshiaki ^a   Hayashi, Tatsuya ^a   Nishioka, Junji ^a   Tamaru, Hiroshi ^a   Akita, Nobuyuki ^a   Asanuma, Kunihiro ^a   Kamada, Haruhiko ^a   Gabazza, Esteban C ^a   Ido, Masaru ^a   Kawamura, Juichi ^a   Suzuki, Koji ^a  

^a MIE UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Protein C inhibitor; Renal cell carcinoma; Tumor invasion; Urinary plasminogen activator

Indexed keywords

ANTIBODY; ANTIGEN; MESSENGER RNA; NUCLEOTIDE; PLASMINOGEN ACTIVATOR INHIBITOR 1; PLASMINOGEN ACTIVATOR INHIBITOR 3; UROKINASE;

ADULT; AGED; ARTICLE; CANCER CELL CULTURE; CANCER INVASION; CANCER TISSUE; CELL PROLIFERATION; CONTROLLED STUDY; EPITHELIUM CELL; EVALUATION; FEMALE; GENETIC TRANSFECTION; HEAT; HUMAN; HUMAN TISSUE; IN VITRO STUDY; KIDNEY CARCINOMA; KIDNEY PROXIMAL TUBULE; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN FUNCTION; REGULATORY MECHANISM; STATISTICAL SIGNIFICANCE;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, RENAL CELL; CELLS, CULTURED; DOWN-REGULATION; FEMALE; HEAT; HUMANS; KIDNEY; KIDNEY NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROMOTER REGIONS (GENETICS); PROTEIN C INHIBITOR; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SERINE PROTEINASE INHIBITORS; TRANSFECTION; URINARY PLASMINOGEN ACTIVATOR;

EID: 9144231236     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/ijc.11594     Document Type: Article

References (32)

1. Suzuki K, Nishioka J, Hashimoto S. Protein C inhibitor. Purification from human plasma and characterization. J Biol Chem 1983;258:163-8.
2. Suzuki K, Nishioka J, Kusumoto H, Hashimoto S. Mechanism of inhibition of activated protein C by protein C inhibitor. J Biochem (Tokyo) 1984;85:187-95.
3. Rezaie AR, Cooper ST, Church FC, Esmon CT. Protein C inhibitor is a potent inhibitor of the thrombin-thrombomodulin complex. J Biol Chem 1995;270:25336-9.
4. Meijers JCM, Kanters DH, Vlooswijk RA, van Erp HE, Hessing M, Bouma BN. Inactivation of human plasma kallikrein and factor XIa by protein C inhibitor. Biochemistry 1988;27:4231-7.
5. Stief TW, Radtke KP, Heimburger N. Inhibition of urokinase by protein C-inhibitor (PCI). Evidence for identity of PCI and plasminogen activator inhibitor 3. Biol Chem Hopper Seyler 1987;368:1427-33.
6. Francis RB, Thomas W. Behavior of protein C inhibitor in intravascular coagulation and liver disease. Thromb Haemost 1984;52:71-4.
7. Laurell M, Christensson A, Abrahamsson PA, Stenflo J, Lilja H. Protein C inhibitor in body fluids. Seminal plasma is rich in inhibitor antigen deriving from cells throughout the male reproductive system. J Clin Invest 1992;89:1094-101.
8. Suzuki K. Protein C inhibitor (PAI-3): structure and multi-function. Fibrinol Proteol 2000;14:133-45.
9. Uhrin P, Dewerchin M, Hilpert M, Chrenek P, Schofer C, Zechmeister-Machhart M, Kronke G, Vales A, Carmeliet P, Binder BR, Geiger M. Disruption of the protein C inhibitor gene results in impaired spermatogenesis and male infertility. J Clin Invest 2000;106:1531-9.
10. Radtke K-P, Fernandez JA, GreenGard JS, Tang WW, Wilson CB, Loskutoff DJ, Scharrer I, Griffin JH. Protein C inhibitor is expressed in tublar cells of human kidney. J Clin Invest 1994;94:2117-24.
11. Stump DC, Thienpoint M, Collen D. Purification and characterization of a novel inhibitor of urokinase from human urine. J Biol Chem 1986;261:12759-66.
12. Andreasen PA, Egelund R, Petersen HH. The plasminogen activation system in tumor growth, invasion, and metastasis. Cell Mol Life Sci 2000;57:25-40.
13. Andreasen PA, Kjoller L, Christensen L, Duffy MJ. The urokinase-type plasminogen activator system in cancer metastasis. Int J Cancer 1997;72:1-22.
14. Bajou K, Noel A, Gerard RD, Masson V, Brunner N, Holst-Hansen C, Skobe M, Fusenig P, Carmeliet P, Collen D, Foidart JM. Absence of host plasminogen activator inhibitor 1 prevents cancer invasion and vascularization. Nat Med 1998;4:923-8.
15. McMahon GA, Petitclerc E, Stefansson S, Smith E, Wong MK, Westrick RJ, Ginsburg D, Brooks PC, Lawrence DA. Plasminogen activator inhibitor-1 regulates tumor growth and angiogenesis. J Biol Chem 2001;276:33964-8.
16. Wagner SN, Atkinson MJ, Thanner S, Wagner C, Schmitt M, Wilhelm O, Rotter M, Hofler H. Modulation of urokinase and urokinase receptor gene expression in human renal cell carcinoma. Am J Pathol 1995;147:183-92.
17. Wagner SN, Atkinson MJ, Thanner A, Schmitt M, Wilhelm O, Rotter M, Hofler H. Type-1 plasminogen activator inhibitor in human renal cell carcinoma. J Pathol 1996;179:95-9.
18. Swiercz R, Wolfe WD, Zaher A, Jankun J. Expression of the plasminogen activation system in kidney cancer correlates with its aggressive phenotype. Clin Cancer Res 1998;4:869-77.
19. Tryggvason K, Hoyhtya M, Salo, T. Proteolytic degradation of extracellular matrix in tumor invasion. Biochim Biophys Acta 1987;907:191-217.
20. Liotta LA, Stetler-Stevenson WG. Tumor invasion and metastasis: imbalance of positive and negative regulation. Cancer Res 1991;51:5054-9.
21. Kugler A, Hemmerlein B, Thelen P, Kallerhoff M, Radzun H-J, Ringert R-H. Expression of metalloproteinase 2 and 9 and their inhibitors in renal cell carcinoma. J Urol 1998;160:1914-8.
22. Suzuki K, Deyashiki Y, Nishioka J, Toma K. Protein C inhibitor: structure and function. Thromb Haemost 1989;61:337-42.
23. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987;162:156-9.
24. Suzuki K, Deyashiki Y, Nishioka J, Kurachi K, Akira M, Yamamoto S, Hashimoto S. Characterization of a cDNA for human protein C inhibitor. A new member of the serine protease inhibitor superfamily. J Biol Chem 1987;262:611-6.
25. Saiki RK, Gelfand DH, Stoffel S, Scharf SJ, Higuchi R, Horn GT, Mullis KB, Erlich HA. Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase. Science 1988;239:487-91.
26. Verde P, Stoppelli MP, Galeffi P, Di Nocera P, Blasi F. Identification and primary sequence of unspliced human urokinase poly(A)+ RNA. Proc Natl Acad Sci USA 1984;81:4727-31.
27. Bruckner A, Filderman AE, Kirchheiemer JC, Binder BR, Remold HG. Endogenous receptor-bound urokinase mediates tissue invasion of human lung carcinoma cell line A549 and Calu-1. Cancer Res 1992;52:3043-7.
28. Liu G, Shuman MA, Cohen RL. Co-expression of urokinase, urokinase receptor, and PAI-1 is necessary for optimum invasiveness of cultured lung cancer cells. Int J Cancer 1995;60:501-6.
29. Chambers SK, Ivins CM, Carcangiu ML. Plasminogen activator inhibitor-1 is an independent poor prognostic factor for survival in advanced stage epithelial ovarian cancer patients. Int J Cancer 1998;79:449-54.
30. Foekens JA, Peters HA, Look MP, Portengen H, Schmitt M, Kramer MD, Brunner N, Janicke F, Meijer-van Gelder ME, Henzen-Logmans SC, van Putten WL, Klijn JG. The urokinase system of plasminogen activation and prognosis in 2,780 breast cancer patients. Cancer Res 2000;60:636-43.
31. Nishioka J, Ma N, Hayashi T, Suzuki K. Protein C inhibitor secreted from activated platelets efficiently, inhibits activated protein C on phosphatidylethanolamine of platelet membrane and microvesicles. J Biol Chem 1998;273:11281-7.
32. Hayashi T, Usui M, Nishioka J, Zhang ZX, Suzuki K. Regulation of the human protein C inhibitor gene expression in HepG2 cells: role of Sp1 and AP2. Biochem J 1998;372:573-82.